WALLIS MOLCHEN to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications WALLIS MOLCHEN has written about Randomized Controlled Trials as Topic.
Connection Strength
0.050
-
Automated summaries of serious adverse events in the hepatitis C antiviral long-term treatment against cirrhosis trial. Clin Trials. 2009 Dec; 6(6):618-27.
Score: 0.050
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.